These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21899144)

  • 21. Paranoid psychosis after DDAVP therapy for Alzheimer's dementia.
    Collins GB; Marzewski DJ; Rollins MB
    Lancet; 1981 Oct; 2(8250):808. PubMed ID: 6116932
    [No Abstract]   [Full Text] [Related]  

  • 22. length of clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Levy R
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():33. PubMed ID: 9305513
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacological treatments of behavioral and psychological symptoms of dementia in Alzheimer's disease: role of acetylcholinesterase inhibitors and memantine.
    Desmidt T; Hommet C; Camus V
    Geriatr Psychol Neuropsychiatr Vieil; 2016 Sep; 14(3):300-6. PubMed ID: 27651011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of naloxone in senile dementia: a double-blind trial.
    Reisberg B; Ferris SH; Anand R; Mir P; Geibel V; De Leon MJ; Roberts E
    N Engl J Med; 1983 Mar; 308(12):721-2. PubMed ID: 6338389
    [No Abstract]   [Full Text] [Related]  

  • 25. Management of Depression in Patients with Dementia: Is Pharmacological Treatment Justified?
    Ford AH; Almeida OP
    Drugs Aging; 2017 Feb; 34(2):89-95. PubMed ID: 28074409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticoagulant therapy for dementia.
    Walsh AC
    J Clin Psychiatry; 1990 Dec; 51(12):522. PubMed ID: 2082987
    [No Abstract]   [Full Text] [Related]  

  • 27. A guideline for the treatment of dementia in Japan.
    Nakamura S
    Intern Med; 2004 Jan; 43(1):18-29. PubMed ID: 14964575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ethical issues in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Post SG; Beerman B; Brodaty H; Gaines AW; Gauthier SG; Geldmacher DS; Hill S; Homma A; Rossor MN; Whitehouse PJ; Winblad B
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():26-8. PubMed ID: 9305511
    [No Abstract]   [Full Text] [Related]  

  • 29. Tacrine for senile dementia of Alzheimer's or Lewy body type.
    Wilcock GK; Scott MI
    Lancet; 1994 Aug; 344(8921):544. PubMed ID: 7914636
    [No Abstract]   [Full Text] [Related]  

  • 30. Single-case study of clinical response to high-dose ergot alkaloid treatment for dementia. Preliminary report.
    Yesavage JA; Tinklenberg JR
    Gerontology; 1981; 27(1-2):76-8. PubMed ID: 7215823
    [No Abstract]   [Full Text] [Related]  

  • 31. Quality-of-life assessment in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Whitehouse PJ; Orgogozo JM; Becker RE; Gauthier S; Pontecorvo M; Erzigkeit H; Rogers S; Mohs RC; Bodick N; Bruno G; Dal-Bianco P
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():56-60. PubMed ID: 9305519
    [No Abstract]   [Full Text] [Related]  

  • 32. [Internal medicine and neurological diseases: progress in diagnosis and treatment. Topics: III. Dyslipidemia and neurological disorders (cerebral infarction, dementia)].
    Hanyu H
    Nihon Naika Gakkai Zasshi; 2012 Aug; 101(8):2188-94. PubMed ID: 22973689
    [No Abstract]   [Full Text] [Related]  

  • 33. [Current antidementive therapy].
    Perneczky R; Kurz A
    MMW Fortschr Med; 2004 May; 146 Spec No 2():53-6. PubMed ID: 15376702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of lecithin on memory in patients with senile dementia of the Alzheimer's type [proceedings].
    Vroulis GA; Smith RC; Brinkman S; Schoolar J; Gordon J
    Psychopharmacol Bull; 1981 Jan; 17(1):127-8. PubMed ID: 7232644
    [No Abstract]   [Full Text] [Related]  

  • 35. Realizing early treatment benefits in dementia.
    Gauthier SG
    Eur J Neurol; 2005 Oct; 12 Suppl 3():1-2. PubMed ID: 16144530
    [No Abstract]   [Full Text] [Related]  

  • 36. Imagining a Role for Psychedelics in Dementia Care.
    George DR; Hanson R
    Am J Geriatr Psychiatry; 2019 Sep; 27(9):1028-1030. PubMed ID: 31047789
    [No Abstract]   [Full Text] [Related]  

  • 37. Another swing of the pendulum.
    Walsh AC
    J Am Geriatr Soc; 1990 Oct; 38(10):1162-3. PubMed ID: 2229873
    [No Abstract]   [Full Text] [Related]  

  • 38. Physostigmine and its effect on six patients with dementia.
    Ashford JW; Soldinger S; Schaeffer J; Cochran L; Jarvik LF
    Am J Psychiatry; 1981 Jun; 138(6):829-30. PubMed ID: 7246817
    [No Abstract]   [Full Text] [Related]  

  • 39. What are the difficulties of implementing innovative pharmacy practice models in the care of patients with dementia?
    Wimo A
    Expert Rev Pharmacoecon Outcomes Res; 2021 Feb; 21(1):1-4. PubMed ID: 33241968
    [No Abstract]   [Full Text] [Related]  

  • 40. Dementia care in nursing homes: a golden opportunity.
    Bonner A
    Int Psychogeriatr; 2014 Mar; 26(3):361-2. PubMed ID: 24476937
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.